XBIO Stock: Xenetic Soars on Private Placement Announcement

68
7
Favorite

XBIO Stock: Xenetic Soars on Private Placement Announcement

investorplace2021-07-27

Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

Titu
·2021-07-27
Ok
Reply
Like
Report
Fold Replies
- JHFG:
  ok
  2021-07-27
  Reply
  Report
Pandachubby
·2021-07-27
Huh
Reply
2
Report
Fold Replies
- Titu:
  Ya
  2021-07-27
  Reply
  Report
DarrenWong
·2021-07-27
OK
Reply
1
Report
JoeKun
·2021-07-27
Okay
Reply
1
Report
Fold Replies
- Tw0d3MooN:
  [微笑]
  2021-07-27
  Reply
  Report
bafeite9
·2021-07-27
Ok
Reply
3
Report
Fold Replies
- N30:
  [Strong]
  2021-07-27
  Reply
  Report
- JoeKun:
  ok
  2021-07-27
  Reply
  Report
sunnylimbs
·2021-07-27
Sure
Reply
3
Report
Fold Replies
- Philentoma:
  Wow
  2021-07-27
  Reply
  Report
Shop
·2021-07-27
ok
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1129201185?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-27 08:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129201185","market":"us","top_or_hot":-1,"title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","media":"investorplace","content":"<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBIO","symbol_name":"Xenetic Biosciences Inc","start_time":0,"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","article_id":"1129201185","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","pubTimestamp":1627347052,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBIO":"Xenetic Biosciences Inc","TAK":"武田制药"},"translate_title":"XBIO股票：Xenetic在定向增发公告中大涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TAK":0.9,"XBIO":0.9},"content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":809362676,"gmtCreate":1627348693295,"gmtModify":1703488055833,"author":{"id":"3558865529132556","authorId":"3558865529132556","authorIdStr":"3558865529132556","name":"Titu","avatar":"https://static.tigerbbs.com/9f0b0e640551e4ad766c10135d80d562","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0,"idStr":"3558865529132556"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/809362676","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5341081,"gmtCreate":1627348851051,"gmtModify":1663231543850,"authorId":3581584136411536,"author":{"id":3581584136411536,"authorId":3581584136411536,"name":"JHFG","avatar":"https://static.tigerbbs.com/e048fb469b216f96902bba2f89b85c19","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809362676,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":809368645,"gmtCreate":1627348613287,"gmtModify":1703488053080,"author":{"id":"3557300951777174","authorId":"3557300951777174","authorIdStr":"3557300951777174","name":"Pandachubby","avatar":"https://static.tigerbbs.com/4219cbe80202ef8b5c370a68f24f052b","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3557300951777174"},"htmlText":"Huh&nbsp;","listText":"Huh&nbsp;","text":"Huh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/809368645","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5341052,"gmtCreate":1627348705499,"gmtModify":1663231544029,"authorId":3558865529132556,"author":{"id":3558865529132556,"authorId":3558865529132556,"name":"Titu","avatar":"https://static.tigerbbs.com/9f0b0e640551e4ad766c10135d80d562","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.87%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809368645,"type":1,"supId":0,"prevId":0,"content":"Ya","text":"Ya","html":"Ya"}],"langContent":"EN"},{"id":809363906,"gmtCreate":1627348513505,"gmtModify":1703488049526,"author":{"id":"3575008828232704","authorId":"3575008828232704","authorIdStr":"3575008828232704","name":"DarrenWong","avatar":"https://static.tigerbbs.com/394b0b4839a3420149c0a1372405c98d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3575008828232704"},"htmlText":"OK","listText":"OK","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/809363906","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":809311492,"gmtCreate":1627347824816,"gmtModify":1703488023064,"author":{"id":"4087524360121530","authorId":"4087524360121530","authorIdStr":"4087524360121530","name":"JoeKun","avatar":"https://static.tigerbbs.com/a543b7a138549431b97b6bee2bc9e956","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087524360121530"},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/809311492","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5340956,"gmtCreate":1627348361119,"gmtModify":1635220679387,"authorId":3581684923109887,"author":{"id":3581684923109887,"authorId":3581684923109887,"name":"Tw0d3MooN","avatar":"https://static.tigerbbs.com/1792a6da317090d0d10ea17a99f1dfa1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809311492,"type":1,"supId":0,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]"}],"langContent":"EN"},{"id":809313242,"gmtCreate":1627347745286,"gmtModify":1703488021280,"author":{"id":"4089207603500750","authorId":"4089207603500750","authorIdStr":"4089207603500750","name":"bafeite9","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4089207603500750"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/809313242","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5340816,"gmtCreate":1627347759624,"gmtModify":1635220690095,"authorId":3570622365838239,"author":{"id":3570622365838239,"authorId":3570622365838239,"name":"N30","avatar":"https://community-static.tradeup.com/news/33bf6a97d91ccaf61eb8245d0322ab01","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":"93.09%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.28","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":809313242,"type":1,"supId":0,"prevId":0,"content":"[Strong]","text":"[Strong]","html":"[Strong]"},{"id":5340830,"gmtCreate":1627347834815,"gmtModify":1635220688907,"authorId":4087524360121530,"author":{"id":4087524360121530,"authorId":4087524360121530,"name":"JoeKun","avatar":"https://static.tigerbbs.com/a543b7a138549431b97b6bee2bc9e956","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809313242,"type":1,"supId":5340816,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":809334029,"gmtCreate":1627347542261,"gmtModify":1703488013815,"author":{"id":"3581734197173658","authorId":"3581734197173658","authorIdStr":"3581734197173658","name":"sunnylimbs","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3581734197173658"},"htmlText":"Sure","listText":"Sure","text":"Sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/809334029","repostId":1129201185,"repostType":2,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5340847,"gmtCreate":1627347919501,"gmtModify":1663231546044,"authorId":3565562352717509,"author":{"id":3565562352717509,"authorId":3565562352717509,"name":"Philentoma","avatar":"https://static.tigerbbs.com/39f36c499dc0d8a19f505543c74bc9a1","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.26","exceedPercentage":"93.41%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":809334029,"type":1,"supId":0,"prevId":0,"content":"Wow","text":"Wow","html":"Wow"}],"langContent":"EN"},{"id":809336985,"gmtCreate":1627347422747,"gmtModify":1703488009936,"author":{"id":"3582022994702843","authorId":"3582022994702843","authorIdStr":"3582022994702843","name":"Shop","avatar":"https://static.tigerbbs.com/d361fd3c4c5677fff3957e6d430ecb52","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582022994702843"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/809336985","repostId":1129201185,"repostType":4,"repost":{"id":"1129201185","pubTimestamp":1627347052,"share":"https://ttm.financial/m/news/1129201185?lang=&edition=fundamental","pubTime":"2021-07-27 08:50","market":"us","language":"en","title":"XBIO Stock: Xenetic Soars on Private Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1129201185","media":"investorplace","summary":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a hea","content":"<p><b>Xenetic Biosciences</b>(NASDAQ:<b><u>XBIO</u></b>) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?</p>\n<p>Xenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner&nbsp;<b>Takeda Pharmaceuticals</b>(NYSE:<b><u>TAK</u></b>) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.</p>\n<p>XBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.</p>\n<p>XBIO Stock Bolstered by Private Sale</p>\n<p>The potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.</p>\n<p>The sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XBIO Stock: Xenetic Soars on Private Placement Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXBIO Stock: Xenetic Soars on Private Placement Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 08:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried...</p>\n\n<a href=\"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TAK":"武田制药","XBIO":"Xenetic Biosciences Inc"},"source_url":"https://investorplace.com/2021/07/xbio-stock-xenetic-soars-on-private-placement-announcement/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129201185","content_text":"Xenetic Biosciences(NASDAQ:XBIO) is continuing a great month for itself. The company is seeing a healthy boost this morning on news of a private placement funding round, just days after it was carried higher by a partners’ expansion news. So, what are the details around this lucrative sale that are allowing XBIO stock to shoot upward again today?\nXenetic is a biopharmaceutical outlet based in Massachusetts; the company specializes primarily in the development and production of cell-based therapeutics that target tumors. The company has been on investors’ radar since last week. XBIO stock shot upward upon announcement that exclusive licensing partner Takeda Pharmaceuticals(NYSE:TAK) would beexpanding its Thousand Oaks facility. This particular facility in California happens to be where Takeda manufactures its biologic products. Since Xenetic’s PolyXen drug-delivery platform is crucial to the manufacturing process, it sent XBIO stock soaring.\nXBIO is up once again today, although this news is entirely the product of Xenetic, rather than a partner. The company isannouncing a coming private placementworth $12.5 million. The company will be selling over 4.6 million XBIO shares to a single healthcare-focused investor. These shares are trading at $2.70 each, per the announcement. The agreement with this institutional investor additionally sees the issuance of warrants to purchase up to 4.6 million shares of common stock at $3.30 a share.\nXBIO Stock Bolstered by Private Sale\nThe potential proceeds of this sale could be as high as $15.3 million for Xenetic’s balance sheet. The company says it will use all proceeds for general working capital purposes. And although we don’t yet know who the investor in this sale is, it’s promising to see hefty institutional support.\nThe sale is working wonders for XBIO stock today. XBIO shares are up over 27% on the day so far, representing growth of 67 cents. Over 101 million shares of XBIO are trading hands today as well, far greater than the daily average of just 5.2 million.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":68,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}